CRA is a sponsor of this Congress.
Richard Wenzel is speaking during a session titled “Innovative Approaches to Patient Finding in Rare Diseases.”
For more information on this event, click here.
How to successfully commercialise microbiome-based diagnostics
In this Med-tech Innovation News article, Andrew Thomson, Brian Carpenter and Robert Broadnax explore key drivers of adoption of microbiome-based diagnostics,...